Sunday, September 25, 2022
HomeHealth InsuranceHealthcare and Life Sciences Trade Outlook: 2022 – Healthcare Economist

Healthcare and Life Sciences Trade Outlook: 2022 – Healthcare Economist






My colleagues at FTI have a new white paper out surveying well being care leaders on developments to anticipate in 2022. The information come from a survey of 251 senior resolution makers working in company
communications, investor relations, public affairs, enterprise growth, R&D and advertising for healthcare and life sciences firms within the U.S. Some key findings:

Drug pricing

Greater than two-thirds (69%) anticipate vital coverage adjustments shall be made on drug pricing below the Biden Administration over the subsequent 12 months.

Status

Variety

Deal-making

Deal-making is anticipated to rise in 2022. Probably the most vital improve is predicted in healthcare IPO exercise, with 65% (+12% since 2020) anticipating it to be larger in 2022,
and 1 in 4 (24%) anticipating it to be “far larger.” Almost 7 in 10 (65%) anticipate M&A exercise to be larger in 2022, rising +5% from final yr, and majority (57%) additionally foresee larger SPAC
exercise in 2022 than within the earlier 12 months.

Hybrid vs. in-person office

In terms of planning a return to the office, 78% are optimistic {that a}
workable steadiness could be discovered. Firms are, nevertheless, break up of their method, with
49% planning to supply a hybrid working method, whereas 43% are contemplating returning to pre-pandemic working.



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments